Traditional SEO is now only part of the search landscape. Patients and HCPs increasingly encounter AI-generated answers before they reach a website. PharmaForward covers the full spectrum — paid, organic, AEO, and GEO — so your brand is present wherever the search actually happens.
For twenty years, biopharma search strategy meant one channel: Google blue links. That model still works. It just covers a shrinking share of how patients and HCPs actually find information.
Google AI Overviews answer health queries before any blue link. Perplexity and ChatGPT are used daily by physicians for clinical research. Your brand’s answer in those tools is either your content or a competitor’s.
PharmaForward builds pharma SEO services across all three search channels — the foundation, the emerging layer, and the AI-native channel — within FDA fair balance requirements and MLR review timelines from day one.
Traditional search visibility — the foundation that everything else builds on. Organic rankings for branded and unbranded disease-state terms, paid search architecture that captures high-intent HCP and patient queries, and the technical infrastructure that signals authority to search engines.
Structuring content to earn citations in Google AI Overviews and featured snippets — the answers that appear before any blue link. Requires MLR-compliant FAQ schema, structured content architecture, and E-E-A-T signals that Google's AI extraction layer trusts.
Earning citations in external AI tools — Perplexity, ChatGPT, Claude, Gemini. Distinct from AEO in that content must be authoritative enough for LLMs to surface it unprompted. Requires content depth, structured data, and domain authority that generative models can reference and attribute.
A biopharma brand can rank first on Google and still be absent from every AI-generated answer a patient reads. The two are different infrastructure. Most biopharma brands have only invested in one.
The brands earning AI citations today started building structured, MLR-compliant content architecture 12-18 months ago. The window is still open — but it's closing faster in rare disease and gene therapy, where patient search volume concentrates around a small number of high-intent queries.
The technical work is the same foundation — schema markup, structured content, authority signals — applied deliberately to where AI is extracting answers.
You rank on Google but don’t appear in AI Overviews. Organic rankings and AI citations use different signals. A page can rank #1 and still be ignored by AI extraction if it lacks the structured data and content depth AI tools require.
Your unbranded disease-state terms are owned by generalist health sites. WebMD, Healthline, and NIH dominate AI citations for most disease states. The window to establish biopharma brand authority in these answers is narrow — but it exists, particularly for rare and orphan disease categories.
Your paid search is spending without an unbranded strategy. Most biopharma paid search budgets are heavily weighted toward branded terms. The patients who could most benefit from your treatment are searching unbranded disease-state terms first. That is the traffic you’re missing.
Your schema markup hasn’t been through MLR review. Schema markup for medical and pharmaceutical content requires FDA fair balance consideration and MLR review. Most schema implementations on biopharma sites were done by developers without either. That creates both compliance risk and missed citation opportunity.
Your HCP site is invisible to HCP search behavior. HCPs search differently than patients — clinical terminology, mechanism of action, dosing protocols. Most biopharma HCP sites are optimized for branded terms only, missing the unbranded clinical queries where prescribing decisions actually start.
Built within FDA fair balance requirements, MLR review timelines, and HIPAA-aware content architecture from day one.
An oncology brand had strong organic rankings for its branded terms but was completely absent from AI-generated search results. When patients searched the disease state, the answers they read came entirely from generalist health sites. The brand had no presence in the answers that preceded every clinical conversation.
PharmaForward built an MLR-compliant schema markup infrastructure across the patient and HCP sites — FAQPage, MedicalCondition, and Drug schema — structured specifically for how Google AI extraction works. Alongside the schema work, we restructured key content pages to directly answer the unbranded queries patients and HCPs were using. Every piece of content went through the standard MLR review pipeline before deployment.
Within 60 days of launch, the brand earned its first Google AI Overview citations for three unbranded disease-state queries. Within 90 days, it appeared in Perplexity answers for two clinical queries. AI search presence, once zero, became a measurable channel with its own reporting track.
Two to three weeks. Organic share-of-voice, paid search architecture, schema markup status, and current AI citation presence across Google AI Overviews, Perplexity, and ChatGPT. Competitive gap analysis against key therapy-area comparators.
MLR-compliant JSON-LD schema markup across patient and HCP properties. Technical SEO remediation. Content architecture aligned to the queries patients and HCPs actually use — structured for both traditional ranking and AI extraction.
Separate HCP and patient campaign architecture. Unbranded disease-state expansion beyond branded terms. Geo-targeting aligned to treatment center geography. Smart Bidding strategy validated against clean conversion data from the analytics foundation.
Ongoing tracking of AI Overview presence, Perplexity citation frequency, and competitive AI share-of-voice. Monthly reporting that treats AI search as its own channel — not an afterthought in a traditional SEO report.
The questions biopharma marketing and digital teams ask most often about pharma SEO services and AI search visibility.
Related: Analytics & Measurement · Marketing Optimization
Two to three weeks. Organic share-of-voice, paid search architecture, schema markup, and your current presence — or absence — in AI-generated answers.
Connect with us